What are the names of some of the hormone therapy drugs for early breast cancer?
1 in 5 breast cancers express high levels of the protein Her2. This is described as Her 2 positive breast cancer. The drug Trastuzumab (Herceptin) consists of a monoclonal antibody that recognises this protein and a chemotherapy drug molecule. By recognising the abnormal protein and binding to it, the treatment concentrates toxic chemotherapy drug around the cancer cells. This treatment may become routinely used for women with early breast cancer whose cancer expresses Her2. The treatment is used in late breast cancer and is undergoing trials in women with early breast cancer.
